The primary objectives of green chemistry are the reduction of generation and use of hazardous substances. In healthcare, the most active areas of research in green chemistry are medication manufacturing and analysis. Analysts take serious steps for converting traditional analytical methods to eco-friendly ones that minimize the negative effects of solvents and chemicals on the environment and improve the healthcare. In the proposed work, two analytical methods are presented for the quantification of Finasteride (FIN) and Tadalafil (TAD) simultaneously in newly launched FDA-approved dosage form without prior separation. The first method is derivative spectrophotometry, which is based on measuring the amplitudes of first derivative spectrophotometric peaks of FIN and TAD in ethanolic solution at 221 nm and 293 nm, respectively. On the other hand, measuring the peak-to-peak amplitudes of second derivative spectrum of TAD solution at 291–299 nm was also performed. Regression equations show good linearity for FIN and TAD in the ranges of 10–60 μg mL−1 and 5–50 μg mL−1, respectively. The second method is the RP-HPLC method, where the chromatographic separation was achieved using the XBridgeTM C18 (150 × 4.6 mm, 5 μm) column. The eluent was the mixture of acetonitrile:phosphate buffer with triethylamine, 1% (v/v) adjusted to pH = 7 in the ratio of 50 : 50 (by volume). The flow rate was 1.0 mL min−1 with DAD-detection at 225 nm. This analytical procedure was linear over the ranges of 10–60 μg mL−1 and 2.5–40 μg mL−1 for FIN and TAD, respectively. The presented methods were validated (regarding ICH guidelines) and statistically compared by applying the t-test and F-test with the reported method. The greenness appraisal was performed using three different tools. The proposed validated methods were found to be green, sensitive, selective, and can be successfully used for quality control test.
1 January 2019 in Journal of Food and Drug Analysis
High performance liquid chromatographic (HPLC) method with a pre-column derivatization based on Hantzsch condensation reaction was applied for simultaneous determination of alendronate sodium (ALN) and its main related impurity, 4-Aminobutanoic acid (ABA) at its pharmacopeial limit. The separation of colored condensation products of ALN and ABA were achieved on Agilent Zobrax Eclipse SB-C18 analytical column (250 × 4.6 mm, 5 μm) using a mobile phase composed of acetonitrile-0.1 M acetate buffer, pH 5.0 (15:85, v/v). The flow rate was 1 mL min-1. The detection was carried out at 340 nm using photo-diode array detector. Peak areas were used for the linear regression line in the range of 10-500 and 0.2-40 μg mL-1 for ALN and ABA, respectively. Different conditions for the optimization of the derivatization reactions as well as for the HPLC measurement were studied. The proposed method was validated for linearity, precision, accuracy, specificity and robustness. This method was used to check the purity of ALN in the presence of ABA (related impurity) at the pharmacopeial limit (0.5%). For comparison purpose, another method was proposed which involves synchronous fluorescence measurement after ALN reaction with fluorescamine. In this method, the third derivative synchronous spectra were estimated as peak to peak measurement from 339 to 370 nm for ALN determination with LOD and LOQ of 24 and 73 ng mL-1, respectively, showing very high sensitivity. Both methods have been applied for determination of the alendronate sodium (ALN) in bulk and pharmaceutical preparations without interference of additives in tablets or oral solution.
Global financial market is still highly threatened by bovine fasciolosis; a parasitic infection, that targets cattle, mainly in tropical regions. Binary combination of Ivermectin (IVER) and Clorsulon (CLO), in challenging concentration ratios, is typically indicated for treatment and control of fasciolosis. Present study aims at smart simultaneous spectrophotometric assay of both compounds at their high ratio in marketed formulation and synthetic mixtures, without any prior separation. Furthermore, their greenness profile was evaluated and compared with previous reported assay methods including the official one. Mathematical-based proposed methods are Dual wavelength, Induced Dual wavelength and First Derivative Ratio methods. Each is developed, optimized and applied to determine simultaneously IVER and CLO at linear ranges of 1–30 and 5–40 μg/mL, respectively. They have been validated according to ICH guidelines. Statistical student t- and F-tests, compared the proposed methods with USP chromatographic technique. Ecological appraisal is accomplished using three independent metrics; Analytical Eco-Scale (AES), Green Analytical Procedure Index (GAPI) and Analytical GREEnness Metric Approach (AGREE). Satisfactory recoveries, ICH compliance and adherence of proposed methods to the ecological safety margin are achieved. Developed methods are eco-friendly, cost effective and can accomplish a routine quantitative quality control for concurrent determination of both drugs. Veterinary antimicrobials need analytical quality control using safer and green methodologies. Data manipulated spectral analyses of IVER and CLO, in ratio 1:10%v/v, is developed and optimized. AES, GAPI and AGREE approaches illustrate the high green compliance in respect to literary reported assays. Furthermore, the United States Pharmacopeia (USP) assay for IVER and CLO in injectable dosage form depends on analysis of each drug separately in the presence of the other drug but it cannot determine both drugs simultaneously at the same time.
1 March 2012 in Journal of Pharmaceutical and Biomedical Analysis